… We performed a systematic literature review and random effects meta‐analysis of studies
externally validating CHA2DS2‐VASc in AF patients not receiving anticoagulants. To explore …

… Similar to the results for CHADS 2 , this meta-analysis showed that the increased risk of a
cardiovascular event was higher in AF patients who had CHA 2 DS 2 -VASc scores ≥2, …

… In this meta-analysis, there is also significant heterogeneity between studies in both the
CHADS 2 and CHA 2 DS 2 -VASc scores. After a meta-regression analysis, heterogeneity was …

… for joining the patient level meta‐analysis, and three shared data regarding anthropometric
measurements, risk factors, major comorbidities, and CHA 2 DS 2 ‐VASc score. The primary …

… included in this meta-analysis are summarized in Table 1 . All of them provided information
about the CHADS 2 score and four of them provided CHA 2 DS 2 -VASc score. Except for …

… For that reason, it was recently postulated that the CHADS 2 and the CHA 2 DS 2 -VASc …
present meta-analysis is to test whether clinical variables included in the CHA 2 DS 2 -VASc …

Background Several studies have compared the discriminative performances of CHA 2 DS
2 -VASc and ATRIA scores, but the results are still disputed. Therefore, we aimed to explore …

… Our meta-analysis of ischemic stroke risk in atrial fibrillation patients suggests that those
with CHA 2 DS 2 -VASc score of 1 may be considered for a novel oral anticoagulant, but …

… We aimed to assess the predictive value of CHA2DS2-VASc score for periprocedural
complications and mortality in Acute Coronary Syndrome (ACS) patients treated with PCI. …

… In this systematic review and meta-analysis, our … DS 2 -VASc score, when compared with
those based on CHADS 2 score. Second, the pooled analysis indicated that CHA 2 DS 2 -VASc …